Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts TVRD Hot Sheet
Join SI Premium – FREE
Tvardi Therapeutics (NASDAQ: TVRD) reported Q2 EPS of ($0.69), $0.01 better than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Tvardi Therapeutics (TVRD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- General Mills beats estimates as cost savings offset volumes
- Crude Inventory Rose 2.97 Million Barrels Last Week - EIA
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
